Swixx BioPharma

Baar, Switzerland Founded: 2013 • Age: 13 yrs
Sales, funding, and finance services are provided to biopharma firms.
Request Access

About Swixx BioPharma

Swixx BioPharma is a company based in Baar (Switzerland) founded in 2013 by Petr Nemec and Stuart Swanson.. Swixx BioPharma has raised $54.94 million across 3 funding rounds from investors including HBM Healthcare Investments, Merieux Equity Partners and SK Capital. The company has 24 employees as of September 30, 2024. Swixx BioPharma has completed 1 acquisition, including Pharma Consulting Group. Swixx BioPharma offers products and services including Pharma Services.

  • Headquarter Baar, Switzerland
  • Employees 24 as on 30 Sep, 2024
  • Founders Petr Nemec, Stuart Swanson
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Swixx Biopharma Ag
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $2.86 M (USD)
    417
    as on Dec 31, 2022
  • Net Profit
    $123.69 K (USD)
    682
    as on Dec 31, 2022
  • EBITDA
  • Total Equity Funding
    $54.94 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    24

    as on Sep 30, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Swixx BioPharma

Swixx BioPharma offers a comprehensive portfolio of products and services, including Pharma Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for launching and distributing partners' innovative medicines globally

People of Swixx BioPharma
Headcount 500-1000
Employee Profiles 85
Board Members and Advisors 5
Employee Profiles
People
Jean-Michel Lespinasse
CEO
People
Petr Pípal
CFO
People
Gabriela Zelenková
Legal Counsel & Secretary
People
Dezső Mártha
COO & Head of Rare Diseases BU & Alliance Management

Unlock access to complete

Board Members and Advisors
people
Petr Němec
Co-founder
people
Stuart Swanson
Chairman
people
Barbara Košir
Board Member
people
Matthias Fehr
Board Member

Unlock access to complete

Funding Insights of Swixx BioPharma

Swixx BioPharma has successfully raised a total of $54.94M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2025 Amount Private Equity Round - Swixx BioPharma Valuation

investors

May, 2021 Amount Series C - Swixx BioPharma Valuation Merieux Equity Partners
Jun, 2017 Amount Seed - Swixx BioPharma Valuation HBM Healthcare Investments
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Swixx BioPharma

Swixx BioPharma has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HBM Healthcare Investments, Merieux Equity Partners and SK Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Pivate equity firm that focuses on investing in healthcare and nutrition companies
Founded Year Domain Location
Life sciences focused VC firm funding companies in the US and Europe
Founded Year Domain Location
A global private investment firm focused on specialty sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Swixx BioPharma

Swixx BioPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pharma Consulting Group. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Regulatory compliance consulting is provided for the biopharma sector.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Swixx BioPharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Swixx Biopharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Swixx BioPharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Swixx Biopharma

Frequently Asked Questions about Swixx BioPharma

When was Swixx BioPharma founded?

Swixx BioPharma was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Where is Swixx BioPharma located?

Swixx BioPharma is headquartered in Baar, Switzerland. It is registered at Baar, Zug, Switzerland.

Who is the current CEO of Swixx BioPharma?

Jean Michel Lespinasse is the current CEO of Swixx BioPharma.

Is Swixx BioPharma a funded company?

Swixx BioPharma is a funded company, having raised a total of $54.94M across 3 funding rounds to date.

How many employees does Swixx BioPharma have?

As of Sep 30, 2024, the latest employee count at Swixx BioPharma is 24.

What is the annual revenue of Swixx BioPharma?

Annual revenue of Swixx BioPharma is $2.86M as on Dec 31, 2022.

What does Swixx BioPharma do?

Swixx BioPharma was established in 2013 in Baar, Switzerland, as a provider of specialized services to the biopharma sector. Sales support, funding management, and various finance-related operations are handled for clients in this industry. The company operates from its Swiss base, assisting biopharma entities with financial and commercial needs across Europe and beyond, with leadership including co-founders Petr Nemec and Stuart Swanson, alongside CEO Jean Michel Lespinasse.

What products or services does Swixx BioPharma offer?

Swixx BioPharma offers Pharma Services.

How many acquisitions has Swixx BioPharma made?

Swixx BioPharma has made 1 acquisition, including Pharma Consulting Group.

Who are Swixx BioPharma's investors?

Swixx BioPharma has 3 investors. Key investors include HBM Healthcare Investments, Merieux Equity Partners, and SK Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available